Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Nutrients|October 14, 2023
Plant Protein but Not Animal Protein Consumption Is Associated with Frailty through Plasma MetabolitesToshiko Tanaka, Jayanta K Das, Yichen Jin, et al.
Journal of Clinical Immunology|June 11, 2009
Chronic arsenic exposure impairs macrophage functions in the exposed individualsNilanjana Banerjee, Saptarshi Banerjee, Rupashree Sen, et al.
Mutation Research|August 26, 2006
Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, IndiaSujata De Chaudhuri, Julie Mahata, Jayanta K Das, et al.
International Journal of Cancer|December 15, 2005
Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking waterPritha Ghosh, Anamika Basu, Julie Mahata, et al.
Molecular Cancer Therapeutics|November 11, 2010
Adamantyl-substituted retinoid-related molecules induce apoptosis in human acute myelogenous leukemia cellsLulu Farhana, Marcia I Dawson, Zebin Xia, et al.
Journal of Medicinal Chemistry|May 10, 2011
Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acidZebin Xia, Lulu Farhana, Ricardo G Correa, et al.
Journal of Medicinal Chemistry|December 6, 2011
Analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid. 2. Impact of 3-chloro group replacement on inhibition of proliferation and induction of apoptosis of leukemia and cancer cell linesZebin Xia, Ricardo G Correa, Jayanta K Das, et al.
Bioorganic & Medicinal Chemistry|February 5, 2017
Total synthesis and cytotoxicity of Leucetta alkaloidsPanduka B Koswatta, Sabha Kasiri, Jayanta K Das, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 2, 2011
Polymorphisms in the TNF-α and IL10 gene promoters and risk of arsenic-induced skin lesions and other nondermatological health effectsNilanjana Banerjee, Sujay Nandy, James K Kearns, et al.
Molecular Cancer Therapeutics|June 3, 2010
ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cellsJyoti Nautiyal, Yingjie Yu, Amro Aboukameel, et al.
Pageof 5